Dissection of phenotype reveals possible association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoter

Schizophrenia Research

Volumn 111, Issue 1-3, 2009, Pages 123-130

  Treutlein, Jens ^a   Mühleisen, Thomas W ^b   Frank, Josef ^a   Mattheisen, Manuel ^b   Herms, Stefan ^b   Ludwig, Kerstin U ^b   Treutlein, Tsendsesmee ^a   Schmael, Christine ^a   Strohmaier, Jana ^a   Bößhenz, Katja Veronika ^a   Breuer, René ^a   Paul, Torsten ^a   Witt, Stephanie H ^a   Schulze, Thomas G ^a   Schlösser, Ralf G M ^c   Nenadic, Igor ^c   Sauer, Heinrich ^c   Becker, Tim ^b   Maier, Wolfgang ^b   Cichon, Sven ^b   Nöthen, Markus M ^b   Rietschel, Marcella ^a   more..

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Association; Case control; GRID1; Haplotype block wise tagging; Lifetime history of major depression; Schizophrenia

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR DELTA 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CPG ISLAND; FEMALE; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTORS, GLUTAMATE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 67349172925     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.03.011     Document Type: Article

References (53)

1. Abecasis G.R., and Cookson W.O. GOLD-graphical overview of linkage disequilibrium. Bioinformatics 16 (2000) 182-183
2. an der Heiden W., Könnecke R., Maurer K., Ropeter D., and Häfner H. Depression in the long-term course of schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 255 3 (2005) 174-184
3. Angelucci F., Brenè S., and Mathé A.A. BDNF in schizophrenia, depression and corresponding animal models. Mol. Psychiatry 10 4 (2005) 345-352
4. Antequera F. Structure, function and evolution of CpG island promoters. Cell Mol. Life Sci. 60 8 (2003) 1647-1658
5. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 2 (2005) 263-265
6. Becker T., and Knapp M. Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet. Epidemiol. 27 1 (2004) 21-32
7. Becker T., Cichon S., Jönson E., and Knapp M. Multiple testing in the context of haplotype analysis revisited: application to case-control data. Ann. Hum. Genet. 69 Pt 6 (2005) 747-756
8. Beneyto M., and Meador-Woodruff J.H. Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia. Synapse 60 8 (2006) 585-598
9. Boks M.P., Leask S., Vermunt J.K., and Kahn R.S. The structure of psychosis revisited: the role of mood symptoms. Schizophr. Res. 93 1-3 (2007) 178-185
10. Boks M.P., Hoogendoorn M., Jungerius B.J., Bakker S.C., Sommer I.E., Sinke R.J., Ophoff R.A., and Kahn R.S. Do mood symptoms subdivide the schizophrenia phenotype? Association of the GMP6A gene with a depression subgroup. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B 6 (2008) 707-711
11. Byrne M., Agerbo E., and Mortensen P.B. Family history of psychiatric disorders and age at first contact in schizophrenia: an epidemiological study. Br. J. Psychiatr. Suppl. 43 (2002) s19-s25
12. Carvalho A.L., Caldeira M.V., Santos S.D., and Duarte C.B. Role of the brain-derived neurotrophic factor at glutamatergic synapses. Br. J. Pharmacol. 153 Suppl 1 (2008) S310-S324
13. Clinton S.M., and Meador-Woodruff J.H. Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder. Neuropsychopharmacology 29 7 (2004) 1353-1362
14. Corvin A., Donohoe G., McGhee K., Murphy K., Kenny N., Schwaiger S., Nangle J.M., Morris D., and Gill M. D-amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia. Neurosci. Lett. 426 2 (2007) 97-100
15. DeLisi L.E., Goldin L.R., Maxwell M.E., Kazuba D.M., and Gershon E.S. Clinical features of illness in siblings with schizophrenia or schizoaffective disorder. Arch. Gen. Psychiatry 44 10 (1987) 891-896
16. Egan M.F., Straub R.E., Goldberg T.E., Yakub I., Callicott J.H., Hariri A.R., Mattay V.S., Bertolino A., Hyde T.M., Shannon-Weickert C., Akil M., Crook J., Vakkalanka R.K., Balkissoon R., Gibbs R.A., Kleinman J.E., and Weinberger D.R. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 101 34 (2004) 12604-12609
17. Fallin M.D., Lasseter V.K., Wolyniec P.S., McGrath J.A., Nestadt G., Valle D., Liang K.Y., and Pulver A.E. Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. Am. J. Hum. Genet. 73 3 (2003) 601-611
18. Fallin M.D., Lasseter V.K., Avramopoulos D., Nicodemus K.K., Wolyniec P.S., McGrath J.A., Steel G., Nestadt G., Liang K.Y., Huganir R.L., Valle D., and Pulver A.E. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am. J. Hum. Genet. 77 6 (2005) 918-936
19. Fangerau H., Ohlraun S., Granath R.O., Nöthen M.M., Rietschel M., and Schulze T.G. Computer-assisted phenotype characterization for genetic research in psychiatry. Hum. Hered. 58 3-4 (2004) 122-130
20. Faraone S.V., Hwu H.G., Liu C.M., Chen W.J., Tsuang M.M., Liu S.K., Shieh M.H., Hwang T.J., Ou-Yang W.C., Chen C.Y., Chen C.C., Lin J.J., Chou F.H., Chueh C.M., Liu W.M., Hall M.H., Su J., Van Eerdewegh P., and Tsuang M.T. Genome scan of Han Chinese schizophrenia families from Taiwan: confirmation of linkage to 10q22.3. Am. J. Psychiatry 163 10 (2006) 1760-1766
21. First M.B., Spitzer R.L., Gibbon M., and Williams J. Structured Clinical Interview for Axis I DSM-IV Disorders (1994), Biometrics Research, New York
22. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., and Altshuler D. The structure of haplotype blocks in the human genome. Science 296 5576 (2002) 2225-2229
23. Gardiner-Garden M., and Frommer M. CpG islands in vertebrate genomes. J. Mol. Biol. 196 (1987) 261-282
24. Gauderman, W.J. and Morrison, J.M., 2006. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. http://hydra.usc.edu/gxe.
25. Georgi A., Jamra R.A., Klein K., Villela A.W., Schumacher J., Becker T., Paul T., Schmael C., Höfels S., Klopp N., Illig T., Propping P., Cichon S., Nöthen M.M., Schulze T.G., and Rietschel M. Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample. Psychiatr. Genet. 17 5 (2007) 308-310
26. Guo S.Z., Huang K., Shi Y.Y., Tang W., Zhou J., Feng G.Y., Zhu S.M., Liu H.J., Chen Y., Sun X.D., and He L. A case-control association study between the GRID1 gene and schizophrenia in the Chinese Northern Han population. Schizophr. Res. 93 1-3 (2007) 385-390
27. Häfner H., Maurer K., Trendler G., an der Heiden W., Schmidt M., and Könnecke R. Schizophrenia and depression: challenging the paradigm of two separate diseases-a controlled study of schizophrenia, depression and healthy controls. Schizophr. Res. 77 1 (2005) 11-24
28. Hamshere M.L., Williams N.M., Norton N., Williams H., Cardno A.G., Zammit S., et al. Genome-wide significant linkage in schizophrenia conditioning on occurrence of depressive episodes. J. Med. Genet. 43 7 (2006) 563-567
29. Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol. Psychiatry 11 9 (2006) 815-836
30. Karolchik D., Baertsch R., Diekhans M., Furey T.S., Hinrichs A., Lu Y.T., Roskin K.M., Schwartz M., Sugnet C.W., Thomas D.J., Weber R.J., Haussler D., and Kent W.J. The UCSC genome browser database. Nucl. Acids Res. 31 1 (2003) 51-54
31. Kendler K.S., and MacLean C.J. Estimating familial effects on age at onset and liability to schizophrenia. I. Results of a large sample family study. Genet. Epidemiol. 7 6 (1990) 409-417
32. Kendler K.S., Karkowski-Shuman L., O'Neill F.A., Straub R.E., MacLean C.J., and Walsh D. Resemblance of psychotic symptoms and syndromes in affected sibling pairs from the Irish Study of High-Density Schizophrenia Families: evidence for possible etiologic heterogeneity. Am. J. Psychiatry 154 2 (1997) 191-198
33. Kim J.S., Kornhuber H.H., Schmid-Burgk W., and Holzmuller B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett. 20 3 (1980) 379-382
34. Kornhuber J., Mack-Burkhardt F., Riederer P., Hebenstreit G.F., Reynolds G.P., Andrews H.B., and Beckmann H. [3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients. J. Neural Transm. 77 2-3 (1989) 231-236
35. Lerer B., Segman R.H., Hamdan A., Kanyas K., Karni O., Kohn Y., Korner M., Lanktree M., Kaadan M., Turetsky N., Yakir A., Kerem B., and Macciardi F. Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24. Mol. Psychiatry 8 5 (2003) 488-498
36. Maier W., Lichtermann D., Minges J., Hallmayer J., Heun R., Benkert O., and Levinson D.F. Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Arch. Gen. Psychiatry 50 11 (1993) 871-883
37. Massat I., Souery D., Del-Favero J., Nothen M., Blackwood D., Muir W., Kaneva R., Serretti A., Lorenzi C., Rietschel M., Milanova V., Papadimitriou G.N., Dikeos D., Van Broekhoven C., and Mendlewicz J. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol. Psychiatry 10 6 (2005) 598-605
38. McGuffin P., Farmer A.E., and Harvey I. A polydiagnostic application of the operational criteria in studies of psychotic illness. Arch. Gen. Psychiatry 48 8 (1991) 764-770
39. McNally L., Bhagwagar Z., and Hannestad J. Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr. 13 6 (2008) 501-510
40. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 3 (1988) 1215
41. Myers S.J., Dingledine R., and Borges K. Genetic regulation of glutamate receptor ion channels. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 221-241
42. O'Connor J.A., Muly E.C., Arnold S.E., and Hemby S.E. AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs. Schizophr. Res. 90 1-3 (2007) 28-40
43. Paus S., Rietschel M., Schulze T.G., Ohlraun S., Diaconu C.C., Van Den Bogaert A., Maier W., Propping P., Cichon S., and Nothen M.M. Systematic screening for mutations in the human N-methyl-D-aspartate receptor 1 gene in schizophrenic patients from the German population. Psychiatr. Genet. 14 4 (2004) 233-234
44. Pilowsky L.S., Bressan R.A., Stone J.M., Erlandsson K., Mulligan R.S., Krystal J.H., and Ell P.J. First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients. Mol. Psychiatry 11 2 (2006) 118-119
45. Pulver A.E., Brown C.H., Wolyniec P., McGrath J., Tam D., Adler L., Carpenter W.T., and Childs B. Schizophrenia: age at onset, gender and familial risk. Acta Psychiatr. Scand. 82 5 (1990) 344-351
46. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A.R., Bender D., Maller J., Sklar P., de Bakker P.I.W., Daly M.J., and Sham P.C. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am. J. Hum. Genet. 81 3 (2007) 559-575
47. Schiffer H.H. Glutamate receptor genes: susceptibility factors in schizophrenia and depressive disorders?. Mol. Neurobiol. 25 2 (2002) 191-212
48. Schulze T.G., and McMahon F.J. Defining the phenotype in human genetic studies: forward genetics and reverse phenotyping. Hum. Hered. 58 3-4 (2004) 131-138
49. Schulze T.G., Ohlraun S., Czerski P.M., Schumacher J., Kassem L., Deschner M., et al. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes. Am. J. Psychiatry 162 11 (2005) 2101-2108
50. Schumacher J., Jamra R.A., Freudenberg J., Becker T., Ohlraun S., Otte A.C., Tullius M., Kovalenko S., Bogaert A.V., Maier W., Rietschel M., Propping P., Nothen M.M., and Cichon S. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol. Psychiatry 9 2 (2004) 203-207
51. Schumacher J., Jamra R.A., Becker T., Ohlraun S., Klopp N., Binder E.B., Schulze T.G., Deschner M., Schmäl C., Höfels S., Zobel A., Illig T., Propping P., Holsboer F., Rietschel M., Nöthen M.M., and Cichon S. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 58 4 (2005) 307-314
52. Siris S.G., and Bench C. Depression and schizophrenia. In: Hirsch S.R., and Weinberger D.R. (Eds). Schizophrenia (2003), Blackwell Publishing, Oxford 142-167
53. Suvisaari J.M., Haukka J., Tanskanen A., and Lönnqvist J.K. Age at onset and outcome in schizophrenia are related to the degree of familial loading. Br. J. Psychiatry 173 (1998) 494-500